These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30887811)

  • 1. An Unbiased Lipid Phenotyping Approach To Study the Genetic Determinants of Lipids and Their Association with Coronary Heart Disease Risk Factors.
    Harshfield EL; Koulman A; Ziemek D; Marney L; Fauman EB; Paul DS; Stacey D; Rasheed A; Lee JJ; Shah N; Jabeen S; Imran A; Abbas S; Hina Z; Qamar N; Mallick NH; Yaqoob Z; Saghir T; Rizvi SNH; Memon A; Rasheed SZ; Memon FU; Qureshi IH; Ishaq M; Frossard P; Danesh J; Saleheen D; Butterworth AS; Wood AM; Griffin JL
    J Proteome Res; 2019 Jun; 18(6):2397-2410. PubMed ID: 30887811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics.
    Yan F; Wen Z; Wang R; Luo W; Du Y; Wang W; Chen X
    BMC Pulm Med; 2017 Dec; 17(1):174. PubMed ID: 29212488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The plasma lipidome of the Quaker parrot (Myiopsitta monachus).
    Beaufrère H; Gardhouse SM; Wood RD; Stark KD
    PLoS One; 2020; 15(12):e0240449. PubMed ID: 33259543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of lipid metabolism biomarkers in patients with coronary heart disease via ultra-performance liquid chromatography-high resolution mass spectrometry.
    Cai F; Ren F; Zhang Y; Ding X; Fu G; Ren D; Yang L; Chen N; Shang Y; Hu Y; Yi L; Zhang H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Apr; 1169():122603. PubMed ID: 33690078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma lipidomics reveal profound perturbation of glycerophospholipids, fatty acids, and sphingolipids in diet-induced hyperlipidemia.
    Miao H; Chen H; Pei S; Bai X; Vaziri ND; Zhao YY
    Chem Biol Interact; 2015 Feb; 228():79-87. PubMed ID: 25619641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rapid LC-MS/MS method for quantitative profiling of fatty acids, sterols, glycerolipids, glycerophospholipids and sphingolipids in grapes.
    Della Corte A; Chitarrini G; Di Gangi IM; Masuero D; Soini E; Mattivi F; Vrhovsek U
    Talanta; 2015 Aug; 140():52-61. PubMed ID: 26048823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UHPSFC/ESI-MS Analysis of Lipids.
    Lísa M; Holčapek M
    Methods Mol Biol; 2018; 1730():73-82. PubMed ID: 29363066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid profiling of brain tissue and blood after traumatic brain injury: A review of human and experimental studies.
    Nessel I; Michael-Titus AT
    Semin Cell Dev Biol; 2021 Apr; 112():145-156. PubMed ID: 33036880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis.
    Saleheen D; Haycock PC; Zhao W; Rasheed A; Taleb A; Imran A; Abbas S; Majeed F; Akhtar S; Qamar N; Zaman KS; Yaqoob Z; Saghir T; Rizvi SNH; Memon A; Mallick NH; Ishaq M; Rasheed SZ; Memon FU; Mahmood K; Ahmed N; Frossard P; Tsimikas S; Witztum JL; Marcovina S; Sandhu M; Rader DJ; Danesh J
    Lancet Diabetes Endocrinol; 2017 Jul; 5(7):524-533. PubMed ID: 28408323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of genome-wide association studies signals for lipids, diabetes, and coronary heart disease: Cardiovascular Biomarker Genetics Collaboration.
    Angelakopoulou A; Shah T; Sofat R; Shah S; Berry DJ; Cooper J; Palmen J; Tzoulaki I; Wong A; Jefferis BJ; Maniatis N; Drenos F; Gigante B; Hardy R; Laxton RC; Leander K; Motterle A; Simpson IA; Smeeth L; Thomson A; Verzilli C; Kuh D; Ireland H; Deanfield J; Caulfield M; Wallace C; Samani N; Munroe PB; Lathrop M; Fowkes FG; Marmot M; Whincup PH; Whittaker JC; de Faire U; Kivimaki M; Kumari M; Hypponen E; Power C; Humphries SE; Talmud PJ; Price J; Morris RW; Ye S; Casas JP; Hingorani AD
    Eur Heart J; 2012 Feb; 33(3):393-407. PubMed ID: 21804106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Separation of Glycolipids/Sphingolipids from Glycerophospholipids on TiO
    Huang Z; Wu Q; Lu H; Wang Y; Zhang Z
    Anal Chem; 2020 Aug; 92(16):11250-11259. PubMed ID: 32667194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic Patterns in Blood Associated With Lipid Traits Predict Incident Coronary Heart Disease Events and Are Enriched for Results From Genome-Wide Association Studies.
    Hedman ÅK; Mendelson MM; Marioni RE; Gustafsson S; Joehanes R; Irvin MR; Zhi D; Sandling JK; Yao C; Liu C; Liang L; Huan T; McRae AF; Demissie S; Shah S; Starr JM; Cupples LA; Deloukas P; Spector TD; Sundström J; Krauss RM; Arnett DK; Deary IJ; Lind L; Levy D; Ingelsson E
    Circ Cardiovasc Genet; 2017 Jan; 10(1):e001487. PubMed ID: 28213390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring lipid biomarkers of coronary heart disease for elucidating the biological effects of gelanxinning capsule by lipidomics method based on LC-MS.
    Gao X; Hu XH; Zhang Q; Wang XJ; Wen XH; Wang Y; Zhang YX; Sun WJ
    Biomed Chromatogr; 2021 Jul; 35(7):e5091. PubMed ID: 33618435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the
    Zhang QH; Yin RX; Chen WX; Cao XL; Chen YM
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29208769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Circulating Metabolites With Risk of Coronary Heart Disease in a European Population: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium.
    Cavus E; Karakas M; Ojeda FM; Kontto J; Veronesi G; Ferrario MM; Linneberg A; Jørgensen T; Meisinger C; Thorand B; Iacoviello L; Börnigen D; Woodward M; Schnabel R; Costanzo S; Tunstall-Pedoe H; Koenig W; Kuulasmaa K; Salomaa V; Blankenberg S; Zeller T;
    JAMA Cardiol; 2019 Dec; 4(12):1270-1279. PubMed ID: 31664431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the future.
    Burgess S; Harshfield E
    Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):124-30. PubMed ID: 26910273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis.
    Richardson TG; Sanderson E; Palmer TM; Ala-Korpela M; Ference BA; Davey Smith G; Holmes MV
    PLoS Med; 2020 Mar; 17(3):e1003062. PubMed ID: 32203549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipidomic characterisation discovery for coronary heart disease diagnosis based on high-throughput ultra-performance liquid chromatography and mass spectrometry.
    Liu C; Zong WJ; Zhang AH; Zhang HM; Luan YH; Sun H; Cao HX; Wang XJ
    RSC Adv; 2018 Jan; 8(2):647-654. PubMed ID: 35538954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Clinical Phenotype and Lipidomic Analysis Reveals the Impact of Chronic Kidney Disease on Lipid Metabolism.
    Chen H; Chen L; Liu D; Chen DQ; Vaziri ND; Yu XY; Zhang L; Su W; Bai X; Zhao YY
    J Proteome Res; 2017 Apr; 16(4):1566-1578. PubMed ID: 28286957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDL Cholesterol Metabolism and the Risk of CHD: New Insights from Human Genetics.
    Vitali C; Khetarpal SA; Rader DJ
    Curr Cardiol Rep; 2017 Nov; 19(12):132. PubMed ID: 29103089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.